Lyell: MWG Entities Report 4.3% Stakes
Rhea-AI Filing Summary
Lyell Immunopharma, Inc. filing amends a Schedule 13G to report that MWG Caph Ltd and Milky Way Investments Group Ltd each beneficially own 1,008,116 shares of Common Stock, representing 4.3% of the class based on 23,328,390 shares outstanding reported in the company's DEF 14A filed April 24, 2026.
The cover page shows each Reporting Person has sole voting and sole dispositive power over the 1,008,116 shares. The amendment is signed by authorized representatives and updates the ownership disclosure for these related entities.
Positive
- None.
Negative
- None.
Insights
Two related entities each report a 4.3% stake in Lyell.
The filing amends beneficial ownership to show MWG Caph Ltd and Milky Way Investments Group Ltd each beneficially own 1,008,116 shares, with sole voting and dispositive power recorded on the cover pages. The percentage is calculated from 23,328,390 shares outstanding per the April 24, 2026 proxy reference.
These positions remain below the 5% reporting threshold for Section 13(d) control presumptions. Subsequent filings may show aggregation or changes if holdings move above regulatory thresholds.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does MWG Caph Ltd report in LYEL?
What voting and dispositive powers are reported for these entities?
On what basis is the 4.3% ownership percentage calculated?
Do these holdings trigger Schedule 13D reporting obligations?
AI-generated analysis. How Rhea-AI works. Not financial advice.